Target intelligence / Profile preview

Immunoglobulin heavy variable 3-52 (IGHV3-52)

Target
IGHV3-52
Molecular classification
Immunoglobulin variable region gene, Immunoglobulin domain, Other
01

Overview

The Immunoglobulin heavy variable 3-52 (IGHV3-52) gene encodes a variable region of the immunoglobulin heavy chain and is part of the immunoglobulin superfamily (IgSF)[1]. This variable region contributes to the antigen-binding domain of antibodies, pairing with light chain variable domains to form the antigen specificity site[1]. IGHV genes, including IGHV3-52, undergo somatic recombination and somatic hypermutation to generate antibody diversity essential for adaptive immune responses[1][2][4]. IGHV3-52 itself is not a drug target or receptor but comprises the genetic blueprint used by B lymphocytes to generate distinct antibodies by recombining with other V, D, and J segments[1][2]. The IGHV3 subclass, to which IGHV3-52 belongs, is known for its polymorphism and impact on antibody repertoire diversity across individuals[2][4]. Dysfunction or polymorphisms in variable segment genes can contribute to altered immunity, but IGHV3-52 is not established as a direct therapeutic target for drugs[1][2][4].

Other names
3-52PIGHV352immunoglobulin variable regionIGHV3-52
02

Biological functions

Antigen bindingAdaptive immune responseGeneration of antibody diversityImmune surveillance
03

Disease associations

Other

Beyond the preview

Go deeper on Immunoglobulin heavy variable 3-52 (IGHV3-52).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin heavy variable 3-52 (IGHV3-52).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call